Captrust Financial Advisors Ardelyx, Inc. Transaction History

Captrust Financial Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.68 - $4.79 $27,065 - $48,374	10,099 New	10,099 $48,000
Q1 2022 May 16, 2022	BUY	$0.65 - $1.18 $1,625 - $2,950	2,500 Added 78.99%	5,665 $6,000
Q4 2021 Feb 14, 2022	BUY	$0.86 - $1.7 $1,431 - $2,830	1,665 Added 111.0%	3,165 $3,000
Q3 2021 Nov 16, 2021	BUY	$1.27 - $8.17 $952 - $6,127	750 Added 100.0%	1,500 $2,000
Q2 2021 Aug 16, 2021	BUY	$6.55 - $8.98 $1,637 - $2,245	250 Added 50.0%	750 $6,000
Q1 2021 May 17, 2021	BUY	$6.1 - $7.69 $3,050 - $3,845	500 New	500 $3,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.